Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Prostate magnetic resonance imaging technique.

Mussi TC, Baroni RH, Zagoria RJ, Westphalen AC.

Abdom Radiol (NY). 2019 Nov 7. doi: 10.1007/s00261-019-02308-5. [Epub ahead of print] Review.

PMID:
31701190
2.

Prostate Imaging-Reporting and Data System Steering Committee: PI-RADS v2 Status Update and Future Directions.

Padhani AR, Weinreb J, Rosenkrantz AB, Villeirs G, Turkbey B, Barentsz J.

Eur Urol. 2019 Mar;75(3):385-396. doi: 10.1016/j.eururo.2018.05.035. Epub 2018 Jun 13.

3.

Magnetic resonance imaging of the prostate: interpretation using the PI-RADS V2.

Torregrosa Andrés A, Otero García M, Sineiro Galiñanes M.

Radiologia. 2017 Mar - Apr;59(2):128-138. doi: 10.1016/j.rx.2016.10.005. Epub 2016 Dec 21. English, Spanish.

4.

A meta-analysis of use of Prostate Imaging Reporting and Data System Version 2 (PI-RADS V2) with multiparametric MR imaging for the detection of prostate cancer.

Zhang L, Tang M, Chen S, Lei X, Zhang X, Huan Y.

Eur Radiol. 2017 Dec;27(12):5204-5214. doi: 10.1007/s00330-017-4843-7. Epub 2017 Jun 27. Review.

PMID:
28656462
6.

Abbreviated Biparametric Prostate MR Imaging in Men with Elevated Prostate-specific Antigen.

Kuhl CK, Bruhn R, Krämer N, Nebelung S, Heidenreich A, Schrading S.

Radiology. 2017 Nov;285(2):493-505. doi: 10.1148/radiol.2017170129. Epub 2017 Jul 20.

PMID:
28727544
7.

PI-RADS Version 2: A Pictorial Update.

Purysko AS, Rosenkrantz AB, Barentsz JO, Weinreb JC, Macura KJ.

Radiographics. 2016 Sep-Oct;36(5):1354-72. doi: 10.1148/rg.2016150234. Epub 2016 Jul 29. Review.

PMID:
27471952
8.

Risk of Clinically Significant Prostate Cancer Associated With Prostate Imaging Reporting and Data System Category 3 (Equivocal) Lesions Identified on Multiparametric Prostate MRI.

Sheridan AD, Nath SK, Syed JS, Aneja S, Sprenkle PC, Weinreb JC, Spektor M.

AJR Am J Roentgenol. 2018 Feb;210(2):347-357. doi: 10.2214/AJR.17.18516. Epub 2017 Nov 7.

PMID:
29112469
9.

Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.

Feng ZY, Wang L, Min XD, Wang SG, Wang GP, Cai J.

Chin Med J (Engl). 2016 Oct 20;129(20):2451-2459. doi: 10.4103/0366-6999.191771.

10.

Comparison of PI-RADS v1 and v2 for multiparametric MRI detection of prostate cancer with whole-mount histological workup as reference standard.

Schaudinn A, Gawlitza J, Mucha S, Linder N, Franz T, Horn LC, Kahn T, Busse H.

Eur J Radiol. 2019 Jul;116:180-185. doi: 10.1016/j.ejrad.2019.04.012. Epub 2019 May 14.

PMID:
31153562
11.

Prostate MRI based on PI-RADS version 2: how we review and report.

Steiger P, Thoeny HC.

Cancer Imaging. 2016 Apr 11;16:9. doi: 10.1186/s40644-016-0068-2.

12.

Comparison of Multiparametric MRI Scoring Systems and the Impact on Cancer Detection in Patients Undergoing MR US Fusion Guided Prostate Biopsies.

Rastinehad AR, Waingankar N, Turkbey B, Yaskiv O, Sonstegard AM, Fakhoury M, Olsson CA, Siegel DN, Choyke PL, Ben-Levi E, Villani R.

PLoS One. 2015 Nov 25;10(11):e0143404. doi: 10.1371/journal.pone.0143404. eCollection 2015.

13.

[Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].

Zuo MZ, Zhao WL, Wei CG, Zhang CY, Wen R, Gu YF, Li MJ, Zhang YY, Wu JF, Li X, Shen JK.

Zhonghua Yi Xue Za Zhi. 2017 Dec 19;97(47):3693-3698. doi: 10.3760/cma.j.issn.0376-2491.2017.47.003. Chinese.

PMID:
29325321
14.

Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.

Di Campli E, Delli Pizzi A, Seccia B, Cianci R, d'Annibale M, Colasante A, Cinalli S, Castellan P, Navarra R, Iantorno R, Gabrielli D, Buffone A, Caulo M, Basilico R.

Eur J Radiol. 2018 Apr;101:17-23. doi: 10.1016/j.ejrad.2018.01.028. Epub 2018 Feb 1.

PMID:
29571792
15.

Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.

Washino S, Okochi T, Saito K, Konishi T, Hirai M, Kobayashi Y, Miyagawa T.

BJU Int. 2017 Feb;119(2):225-233. doi: 10.1111/bju.13465. Epub 2016 Apr 1.

16.

Evaluating the performance of PI-RADS v2 in the non-academic setting.

Jordan EJ, Fiske C, Zagoria RJ, Westphalen AC.

Abdom Radiol (NY). 2017 Nov;42(11):2725-2731. doi: 10.1007/s00261-017-1169-5.

PMID:
28451763
17.

Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?

Hoffmann R, Logan C, O'Callaghan M, Gormly K, Chan K, Foreman D.

Int Urol Nephrol. 2018 Jan;50(1):13-19. doi: 10.1007/s11255-017-1753-1. Epub 2017 Nov 29.

PMID:
29188489
18.

Impact of Clinical History on Maximum PI-RADS Version 2 Score: A Six-Reader 120-Case Sham History Retrospective Evaluation.

Shankar PR, Kaza RK, Al-Hawary MM, Masch WR, Curci NE, Mendiratta-Lala M, Sakala MD, Johnson TD, Davenport MS.

Radiology. 2018 Jul;288(1):158-163. doi: 10.1148/radiol.2018172619. Epub 2018 Apr 17.

PMID:
29664338
19.

A Prospective Accuracy Study of Prostate Imaging Reporting and Data System Version 2 on Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer With Whole-mount Pathology.

Giannarini G, Girometti R, Crestani A, Rossanese M, Calandriello M, Cereser L, Bednarova S, Battistella C, Sioletic S, Zuiani C, Valotto C, Ficarra V.

Urology. 2019 Jan;123:191-197. doi: 10.1016/j.urology.2018.07.067. Epub 2018 Sep 28.

PMID:
30273613
20.

Prostate zonal anatomy correlates with the detection of prostate cancer on multiparametric magnetic resonance imaging/ultrasound fusion-targeted biopsy in patients with a solitary PI-RADS v2-scored lesion.

Syed JS, Nguyen KA, Nawaf CB, Bhagat AM, Huber S, Levi A, Humphrey P, Weinreb JC, Schulam PG, Sprenkle PC.

Urol Oncol. 2017 Sep;35(9):542.e19-542.e24. doi: 10.1016/j.urolonc.2017.04.011. Epub 2017 May 10.

PMID:
28501565

Supplemental Content

Support Center